Experts are advocating for the increased use of radiopharmaceutical therapy in cancer treatment, highlighting its advantages over conventional chemotherapy, such as targeting cancer cells with greater precision and minimizing harm to healthy tissues. This call to action was made at the 2026 International Symposium on Radiopharmaceutical Therapy held in Lagos, Nigeria, where specialists discussed advancements in precision oncology and the future of cancer care in Africa. Dr. Emeka Eze and Dr. Marsha Maharaj, notable speakers at the symposium, emphasized that this targeted treatment approach not only reduces chemotherapy's side effects but also allows for better patient outcomes and quality of life. They noted the need for patients to be educated about their treatment options and the importance of addressing the high costs associated with advanced cancer therapies. The symposium served as a platform for training healthcare professionals and fostering local expertise in nuclear medicine to improve cancer care across Nigeria and the continent.
Tue, 01 Sep 2026 07:46:12 GMT | Arise News